Moderna SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KNov. 6, 2026, 6:47 a.m. ETView on SEC.gov Our explainer
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedModerna Q3 2026 GAAP EPS of $0.38 beats -$1.25 consensus on $1.3 billion revenue; raises 2026 revenue growth outlook to 15%-25%
8-KSept. 30, 2026, 7:15 a.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
8-KSept. 1, 2026, 4:37 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Creation of a direct financial obligation · Unregistered sales of equity securities · Other events · Financial statements and exhibits
8-KJuly 31, 2026, 7:03 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits